Sign in

CIK 0001585608

  • Non-accelerated filer
  • Smaller reporting company

Jaguar Health, Inc.

Sign in to watch
Ticker
JAGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-371-8300
Business address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Former names
Jaguar Animal Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-18 BOCHNOWSKI JAMES J Director Grant or award · Restricted stock units +39,400 39,400
2021-04-05 Lizak Carol R. Chief Financial Officer Grant or award · Stock option (right to buy) +81,250 81,250
2021-04-05 Lizak Carol R. Chief Financial Officer Grant or award · Restricted stock units +40,625 40,625
2018-09-25 Nantucket Investments Ltd 10% owner Sale −325,615 $1.83 $596K 0
2018-09-25 Nantucket Investments Ltd 10% owner Sale · Non-Voting Common Stock +270,270 $1.83 $495K 38,180,451

Page 10 of 10 · 185 trades